Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres
- PMID: 22969298
- PMCID: PMC3435120
- DOI: 10.2147/IJN.S34312
Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres
Abstract
Background and methods: A dual (immediate/sustained-release) oral amoxicillin suspension was developed as a new dosage form to eradicate Helicobacter pylori. Carbopol®-loaded amoxicillin nanospheres could bind with the mucosa after delivery to the stomach and could increase the efficiency of the drug, providing both an immediate and a sustained action.
Results: The objective of this research was to develop amoxicillin nanospheres using a spray-drying technique and to investigate such features as their particle size, drug content, percentage yield, surface morphology, in vitro release, and stability. The nanospheres had a particle size range of 280-320 nm after optimizing the preparation method using a central composite design. The drug content and percentage yield was 85.3% ± 0.7% and 92.8% ± 0.9%, respectively. The in vitro release profile of the amoxicillin nanospheres was consistent with a Korsmeyer-Peppas pattern, and the release after one hour was 19%, while for the original drug, amoxicillin, under the same conditions, 90% was released in the first 30 minutes.
Conclusion: The nanospheres used in this study enabled controlled release of amoxicillin over an extended period of time for up to 12 hours and the formulation was stable for 12 months.
Keywords: Helicobacter pylori; amoxicillin; nano spraydryer; nanospheres; optimization.
Figures








Similar articles
-
Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization.Drug Des Devel Ther. 2013 Sep 26;7:1027-33. doi: 10.2147/DDDT.S39956. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24101859 Free PMC article.
-
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.Drug Deliv. 2016;23(2):405-19. doi: 10.3109/10717544.2014.916766. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24870198
-
Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.J Microencapsul. 2009 Jun;26(4):365-76. doi: 10.1080/02652040802373012. J Microencapsul. 2009. PMID: 18720199
-
[Helicobacter pylori induced gastritis: recent topics on eradication therapy].Nihon Shokakibyo Gakkai Zasshi. 2002 Nov;99(11):1312-6. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12462049 Review. Japanese. No abstract available.
-
[Current therapy of Helicobacter pylori infection].Leber Magen Darm. 1994 Feb;24(1):5-9. Leber Magen Darm. 1994. PMID: 8145628 Review. German. No abstract available.
Cited by
-
Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization.Drug Des Devel Ther. 2013 Sep 26;7:1027-33. doi: 10.2147/DDDT.S39956. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24101859 Free PMC article.
-
Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy.Pharmaceutics. 2025 May 22;17(6):683. doi: 10.3390/pharmaceutics17060683. Pharmaceutics. 2025. PMID: 40573997 Free PMC article. Review.
-
Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation.Heliyon. 2023 Sep 24;9(10):e20406. doi: 10.1016/j.heliyon.2023.e20406. eCollection 2023 Oct. Heliyon. 2023. PMID: 37810864 Free PMC article. Review.
-
Nanoparticle formulation by Büchi B-90 Nano Spray Dryer for oral mucoadhesion.Drug Des Devel Ther. 2015 Jan 23;9:273-82. doi: 10.2147/DDDT.S66654. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25670882 Free PMC article.
-
An Efficient, Lung-Targeted, Drug-Delivery System To Treat Asthma Via Microparticles.Drug Des Devel Ther. 2019 Dec 27;13:4389-4403. doi: 10.2147/DDDT.S216660. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31920288 Free PMC article.
References
-
- Hejazi R, Amiji M. Stomach-specific anti-H. pylori therapy. I: preparation and characterization of tetracycline-loaded chitosan microspheres. Int J Pharm. 2002;235(1–2):87–94. - PubMed
-
- Krueger S, Roessner A, Kuester D. Murine models of H. pylori-induced gastritis and gastric adenocarcinoma. Pathol Res Pract. 2011;207(10):599–607. - PubMed
-
- Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med. 1991;324(15):1043–1048. - PubMed
-
- Meurer LN, Bower DJ. Management of Helicobacter pylori infection. Am Fam Physician. 2002;65(7):1327–1336. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources